Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on

Carl J Pepine1, Keith C Ferdinand2, Leslee J Shaw3

  • 1Division of Cardiology, University of Florida, Gainesville, Florida.

Insights

Delayed recognition of ischemic heart disease (IHD) in women hinders timely care. Understanding sex-specific IHD pathophysiology, including nonobstructive coronary artery disease (CAD), is crucial for improving diagnosis and treatment.

Area of Science:

  • Cardiology
  • Women's Health
  • Pathophysiology

Background:

  • Ischemic heart disease (IHD) recognition is often delayed in women.
  • This delay is linked to sex-specific IHD pathophysiology differing from traditional male-centric models.
  • Women with symptoms are less likely to have obstructive coronary artery disease (CAD).

Purpose of the Study:

  • To summarize current knowledge on IHD in women, focusing on nonobstructive CAD.
  • To identify knowledge gaps in IHD diagnosis and management for women.
  • To recommend management strategies pending further evidence.

Main Methods:

  • Literature review and synthesis of emerging data.
  • Analysis of sex-specific IHD pathophysiology.
  • Position paper development.

Main Results:

  • Women often present with nonobstructive CAD, coronary microvascular dysfunction, plaque erosion, and thrombus formation.
  • Nonobstructive CAD, hypertension, and diabetes are associated with adverse events similar to obstructive CAD.
  • A paradigm shift is needed to consider nonobstructive CAD as a cause of IHD in women.

Conclusions:

  • Current IHD models based on men are insufficient for women.
  • Nonobstructive CAD is an emerging cause of IHD and adverse outcomes in women.
  • Revised diagnostic and treatment strategies are needed for women with IHD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
970
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
563
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
410
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
851